NO851054L - Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte 2-oksindol-1-karbokamider - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte 2-oksindol-1-karbokamider

Info

Publication number
NO851054L
NO851054L NO851054A NO851054A NO851054L NO 851054 L NO851054 L NO 851054L NO 851054 A NO851054 A NO 851054A NO 851054 A NO851054 A NO 851054A NO 851054 L NO851054 L NO 851054L
Authority
NO
Norway
Prior art keywords
alkyl
optionally substituted
preparation
ocsindol
carbocamides
Prior art date
Application number
NO851054A
Other languages
English (en)
Other versions
NO165799C (no
NO165799B (no
Inventor
Saul Bernard Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO851054L publication Critical patent/NO851054L/no
Publication of NO165799B publication Critical patent/NO165799B/no
Publication of NO165799C publication Critical patent/NO165799C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
NO851054A 1984-03-19 1985-03-18 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte 2-oksindol-1-karboksamider og mellomprodukter for anvendelse ved fremgansmaaten. NO165799C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59065984A 1984-03-19 1984-03-19
US06/684,634 US4556672A (en) 1984-03-19 1984-12-21 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents

Publications (3)

Publication Number Publication Date
NO851054L true NO851054L (no) 1985-09-20
NO165799B NO165799B (no) 1991-01-02
NO165799C NO165799C (no) 1991-04-10

Family

ID=27080909

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851054A NO165799C (no) 1984-03-19 1985-03-18 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte 2-oksindol-1-karboksamider og mellomprodukter for anvendelse ved fremgansmaaten.

Country Status (36)

Country Link
US (1) US4556672A (no)
EP (1) EP0156603B1 (no)
JP (1) JPH04235165A (no)
KR (1) KR860001873B1 (no)
AT (1) ATE45731T1 (no)
AU (1) AU549927B2 (no)
BG (1) BG60347B2 (no)
CA (2) CA1251441A (no)
CS (1) CS249539B2 (no)
CY (1) CY1668A (no)
DE (1) DE3572481D1 (no)
DK (1) DK162090C (no)
EG (1) EG17795A (no)
ES (1) ES8603408A1 (no)
FI (2) FI82042C (no)
GR (1) GR850668B (no)
HK (1) HK78392A (no)
HU (1) HU196178B (no)
IE (1) IE57743B1 (no)
IL (3) IL74631A (no)
LV (1) LV5618A3 (no)
MA (1) MA20380A1 (no)
MY (1) MY101987A (no)
NL (1) NL940025I2 (no)
NO (1) NO165799C (no)
NZ (2) NZ211486A (no)
OA (1) OA07966A (no)
PH (2) PH21323A (no)
PL (1) PL145951B1 (no)
PT (1) PT80117B (no)
RO (1) RO90952B (no)
SI (1) SI8510440A8 (no)
SU (1) SU1445556A3 (no)
UA (1) UA6343A1 (no)
YU (1) YU43870B (no)
ZW (1) ZW4785A1 (no)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0276500B1 (en) * 1984-02-07 1991-05-15 Pfizer Inc. 2-oxindole intermediates
US4686224A (en) * 1984-10-31 1987-08-11 Pfizer Inc. Oxindole antiinflammatory agents
ATE67185T1 (de) * 1985-07-09 1991-09-15 Pfizer Substituierte oxindol-3-carboxamine als entzuendungshemmendes und schmerzstillendes mittel.
US4678802A (en) * 1985-07-09 1987-07-07 Pfizer Inc. 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents
GB8623819D0 (en) * 1986-10-03 1986-11-05 Glaxo Group Ltd Heterocyclic compounds
WO1988005656A1 (en) * 1987-02-02 1988-08-11 Pfizer Inc. Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide
US4761485A (en) * 1987-03-11 1988-08-02 Pfizer Inc. Synthetic method for indol-2(3H)-ones
US4885370A (en) * 1987-03-11 1989-12-05 Pfizer Inc. Synthetic method for indol-2(3H)-ones
GB8720693D0 (en) * 1987-09-03 1987-10-07 Glaxo Group Ltd Chemical compounds
DE3803775A1 (de) * 1988-02-09 1989-08-17 Boehringer Mannheim Gmbh Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
SK590689A3 (en) * 1988-10-18 1996-03-06 Pfizer 3-aryl-2-oxindole-1-carboxamides and method of their preparation
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
WO1990008145A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5300655A (en) * 1989-04-18 1994-04-05 Pfizer Inc. 2-carboxy-thiophene derivatives
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis
WO1991009598A1 (en) * 1990-01-05 1991-07-11 Pfizer Inc. Azaoxindole derivatives
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5064851A (en) * 1990-07-24 1991-11-12 Pfizer Inc. 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use
US5095031A (en) * 1990-08-20 1992-03-10 Abbott Laboratories Indole derivatives which inhibit leukotriene biosynthesis
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111306C2 (de) * 1991-04-08 1994-06-01 Mack Chem Pharm Pharmazeutische Zubereitungen, die ein 2-Oxindol-l-carboxamid-derivat enthalten und zur Injektion bestimmt sind
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
US5210212A (en) * 1991-06-25 1993-05-11 Pfizer Inc Process for 5-fluoro-6-chlorooxindole
US5166401A (en) * 1991-06-25 1992-11-24 Pfizer Inc Intermediates for 5-fluoro-6-chlorooxindole
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions
US5288743A (en) * 1992-11-20 1994-02-22 Abbott Laboratories Indole carboxylate derivatives which inhibit leukotriene biosynthesis
US5298522A (en) * 1993-01-22 1994-03-29 Pfizer Inc. 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
EP0680321B1 (en) * 1993-01-22 1998-09-23 Pfizer Inc. Lysine salt of 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide
US5270331A (en) * 1993-01-26 1993-12-14 Pfizer, Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
EP0683777B1 (en) * 1993-02-09 1996-11-13 Pfizer Inc. Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-[n-carboxamido]carboxamides as intiinflammatory agents
ES2076106B1 (es) * 1993-08-26 1996-06-16 Pfizer Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas
US5449788A (en) * 1994-01-28 1995-09-12 Catalytica, Inc. Process for preparing 2-oxindole-1-carboxamides
EP0679396A1 (en) * 1994-03-02 1995-11-02 Pfizer Inc. Use of 3-substituted-2-oxidole-1-carboxamides for the manufacture of a medicament in the treatment and prevention of ischemia induced myocardial injury and cytokine mediated myocardial injury
US6469181B1 (en) 1995-01-30 2002-10-22 Catalytica, Inc. Process for preparing 2-oxindoles and N-hydroxy-2-oxindoles
US5545656A (en) * 1995-04-05 1996-08-13 Pfizer Inc. 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease
US6043232A (en) * 1997-07-23 2000-03-28 Nitromed, Inc. Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
US6051588A (en) * 1995-04-19 2000-04-18 Nitromed Inc Nitroso esters of β-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
HUP9600855A3 (en) * 1996-04-03 1998-04-28 Egyt Gyogyszervegyeszeti Gyar Process for producing tenidap
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
JP2002528495A (ja) 1998-10-30 2002-09-03 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化された非ステロイド抗炎症性化合物、組成物および使用方法
AU760039B2 (en) 1998-12-17 2003-05-08 F. Hoffmann-La Roche Ag 4-aryloxindoles as inhibitors of JNK protein kinases
CN1138773C (zh) 1998-12-17 2004-02-18 霍夫曼-拉罗奇有限公司 4-链烯基(和炔基)氧吲哚作为细胞周期蛋白-依赖性激酶尤其是cdk2的抑制剂
JP2002532503A (ja) 1998-12-17 2002-10-02 エフ．ホフマン−ラ ロシュ アーゲー プロテインキナーゼ阻害剤としての４，５−ピラジノオキシンドール
US6153634A (en) 1998-12-17 2000-11-28 Hoffmann-La Roche Inc. 4,5-azolo-oxindoles
IT1308633B1 (it) 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
AU2119001A (en) * 1999-10-26 2001-05-08 University Of Texas Southwestern Medical Center, The Methods of treating hair loss comprising administering indoline compound
US6313310B1 (en) 1999-12-15 2001-11-06 Hoffmann-La Roche Inc. 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
IT1318673B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Farmaci per le disfunzioni sessuali.
IT1318674B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Faramaci per l'incontinenza.
WO2003009815A2 (en) 2001-07-25 2003-02-06 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
EP3395372B1 (en) 2009-02-20 2022-04-06 EnhanX Biopharm Inc. Glutathione-based drug delivery system
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN102911105B (zh) * 2012-11-12 2013-12-04 辽宁科技大学 一种3-芳酰基吲哚化合物的合成方法
EP3277275A4 (en) * 2015-03-31 2018-07-11 Monsanto Technology LLC Processes for the preparation of 2-thiophenecarbonyl chloride
WO2016179157A1 (en) 2015-05-05 2016-11-10 Carafe Drug Innovation, Llc Substituted 5-hydroxyoxindoles and their use as analgesics and fever reducers
MX2018011529A (es) 2016-03-24 2019-02-20 Monsanto Technology Llc Procesos para la preparacion de acidos heteroaril carboxilicos.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125443C (no) * 1963-06-06
US3462450A (en) * 1966-06-29 1969-08-19 Merck & Co Inc Chemical compounds
GB1158532A (en) * 1967-01-05 1969-07-16 Centre Nat Rech Scient 2-Oxoindoline-3-Carboxylic Acids and Esters thereof
US3631177A (en) * 1967-04-18 1971-12-28 Smith Kline French Lab 3-phenacyl-2-oxoindolines
US3519592A (en) * 1967-04-18 1970-07-07 Smithkline Corp Indole compounds
BE714717A (no) * 1967-05-12 1968-09-30
FR7337M (no) * 1968-01-11 1969-10-13
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
DE2306374A1 (de) * 1973-02-09 1974-08-15 Bayer Ag Neue 3-substituierte 2-oxo-4-hydroxy1,2,3,4-tetrahydrochinazolin-4-carbonsaeureamide
US4012394A (en) * 1973-02-16 1977-03-15 Labaz Indole derivatives
DE2314242A1 (de) * 1973-03-22 1974-09-26 Bayer Ag Neue 3-substituierte 2-oxo-4-hydroxy1,2,3,4-tetrahydrochinazolin-4-carbonsaeurehydrazide
US3975531A (en) * 1973-10-02 1976-08-17 A. H. Robins Company, Incorporated 4-(5- And 7-)benzoylindolin-2-ones and pharmaceutical uses thereof

Also Published As

Publication number Publication date
PH21323A (en) 1987-09-28
OA07966A (fr) 1987-01-31
GR850668B (no) 1985-07-16
IL85130A0 (en) 1988-06-30
HU196178B (en) 1988-10-28
RO90952B (ro) 1987-03-01
HUT37398A (en) 1985-12-28
YU44085A (en) 1988-02-29
IE850684L (en) 1985-09-19
PL145951B1 (en) 1988-12-31
LV5618A3 (lv) 1994-05-10
PT80117B (pt) 1987-10-20
PT80117A (en) 1985-04-01
SI8510440A8 (sl) 1996-06-30
KR860001873B1 (ko) 1986-10-24
DE3572481D1 (en) 1989-09-28
IL74631A0 (en) 1985-06-30
CS249539B2 (en) 1987-03-12
FI82042C (fi) 1991-01-10
IL85130A (en) 1988-07-31
EP0156603B1 (en) 1989-08-23
PH21470A (en) 1987-10-28
CA1251441A (en) 1989-03-21
NL940025I1 (nl) 1995-02-01
DK162090B (da) 1991-09-16
IL74631A (en) 1988-07-31
ZW4785A1 (en) 1985-06-19
FI82042B (fi) 1990-09-28
DK121385A (da) 1985-09-20
FI894540A (fi) 1989-09-26
EG17795A (en) 1990-08-30
IE57743B1 (en) 1993-03-24
NZ211486A (en) 1988-10-28
NZ224134A (en) 1988-10-28
PL252434A1 (en) 1985-12-03
ATE45731T1 (de) 1989-09-15
BG60347B2 (bg) 1994-06-30
UA6343A1 (uk) 1994-12-29
CA1288422C (en) 1991-09-03
RO90952A (ro) 1987-02-27
MA20380A1 (fr) 1985-10-01
FI82449B (fi) 1990-11-30
FI82449C (fi) 1991-03-11
DK121385D0 (da) 1985-03-18
MY101987A (en) 1992-02-29
ES541372A0 (es) 1985-12-16
FI894540A0 (fi) 1989-09-26
CY1668A (en) 1993-05-14
NO165799C (no) 1991-04-10
JPH04235165A (ja) 1992-08-24
JPH0561269B2 (no) 1993-09-06
NO165799B (no) 1991-01-02
SU1445556A3 (ru) 1988-12-15
EP0156603A2 (en) 1985-10-02
EP0156603A3 (en) 1986-02-12
US4556672A (en) 1985-12-03
NL940025I2 (nl) 2000-01-03
ES8603408A1 (es) 1985-12-16
AU4005985A (en) 1985-09-26
FI851069L (fi) 1985-09-20
FI851069A0 (fi) 1985-03-18
HK78392A (en) 1992-10-23
DK162090C (da) 1992-02-24
AU549927B2 (en) 1986-02-20
YU43870B (en) 1989-12-31
KR850006173A (ko) 1985-10-02

Similar Documents

Publication Publication Date Title
NO851054L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte 2-oksindol-1-karbokamider
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
NO854941L (no) Fremgangsmaate for fremstilling av terapeutisk aktive, sure indol-derivater.
NO881835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
ATE27813T1 (de) N-substituierte 1-(4'-alkylsulfonylphenyl)-2amino-1,3-propanediol-derivate.
NO168173C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater
FI891807A (fi) Menetelmä terapeuttisesti aktiivisten oktahydropyrrolo-pyratsino/2,1-i/indol-2-oni-johdannaisten valmistamiseksi
ATE18993T1 (de) Dibenzocycloheptenyliden-verbindungen zur verwendung bei der modulation der immunreaktion.
ATE56440T1 (de) 6-oxo-pyridazinyl-verbindungen.

Legal Events

Date Code Title Description
MK1K Patent expired